The induction of cytotoxic T lymphocytes against HLA-A locus-matched lung adenocarcinoma in patients with non-small cell lung cancer

Japanese Journal of Cancer Research

Volumn 88, Issue 8, 1997, Pages 743-749

  Yoshino, Ichiro ^a   Takenoyama, Mitsuhiro ^a   Fujie, Hiroshi ^a   Hanagiri, Takeshi ^a   Yoshimatsu, Takashi ^a   Imabayashi, Satoshi ^a   Eifuku, Ryouzo ^a   Ogami, Akira ^a   Yano, Koichi ^a   Osaki, Toshihiro ^a   Nakanishi, Ryoichi ^a   Ichiyoshi, Yuji ^a   Nomoto, Kikuo ^b   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cytotoxic T lymphocyte; Lymph node lymphocyte; MHC class I; Non small cell lung cancer; Tumor infiltrating lymphocyte

Indexed keywords

CHROMIUM 51; GAMMA INTERFERON; HLA A ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030868451     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00446.x     Document Type: Article

References (26)

1. Grili, R., Oxman, A. D. and Julian, J. A. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J. Clin. Oncol., 11, 1855-1872 (1993).
2. Damstrup, L. and Poulson, H. S. Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer. Lung Cancer, 11, 153-178 (1994).
3. Mountain, C. F. and Gail, M. H. for the Lung Cancer Study Group. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group. J. Thorac. Cardiovasc. Surg., 82, 649-657 (1981).
4. Cheddar, E. and Klieg, E. Cancer immunotherapy: are the results discouraging? Can they be improved? Adv. Cancer Res., 59, 245-322 (1992).
5. Rosenberg, S. A., Lotze, M. T., Yang, J. C., Aebersold, P. M., Linehan, W. M., Seipp, C. A. and Bradley, E. C. Experience with the use of high-dose interleukin-2 in the treatment of 654 cancer patients. Ann. Surg., 210, 474-485 (1989).
6. Kradin, R. L., Kurnick, J. T., Lazarus, D. S., Preffer, F., Debinett, S. M., Pinto, C. E., Giford, J., Davidson, E., Grove, B., Callahan, R. J., Strauss, H. W. Tumor-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet, i, 577-580 (1989).
7. Yasumoto, K., Ohta, O. and Nomoto, K. Cytotoxic activity of carcinoma cells in patients with lung cancer. Gann, 67, 505-511 (1976).
8. Voce, B. M. and Bond, G. D. Human tumor antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells. Nature, 296, 359-361 (1982).
9. Kurnick, J. T., Kradin, R. L., Blumberg, R., Schneeberger, E. E. and Boyle, L. A. Functional characterization of T lymphocytes propagated from human lung carcinoma. Clin. Immunol. Immunopathol., 38, 367-380 (1986).
10. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., van den Eynde, B., Knuth, A. and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
11. Boël, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J. C., Coulie, P., Boon, T. and van der Bruggen, P. Bage, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2, 167-175 (1995).
12. van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S. and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 181, 689-698 (1995).
13. Wölfel, T., Pel, A. V., Brichard, V., Schbider, J., Seliger, B., zum Büschenfelde, K. H. and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol., 24, 759-764 (1994).
14. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T. and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumors. Proc. Natl. Acad. Sci. USA, 91, 3515-3519 (1994).
15. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appela, E., Yanneli, J. R, Adema, G. J., Miki, T. and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91, 6458-6462 (1994).
16. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., van Pel, A., De Plaen, E., Amar-Costesec, A. and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytotoxic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176, 1453-1457 (1992).
17. Gaugler, B., van den Eynde, B., Knuth, A. and Boon, T. Human fene MAGE-3 codes for an antigen recognized on a melanoma by autologous T lymphocytes. J. Exp. Med., 179, 921-930 (1994).
18. Kang, X., Kawakami, Y., El-Gamil, M., Wang, R., Sakaguchi, K., Yanneli, J. R., Appella, E., Rosenberg, S. A. and Robbins, P. F. Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J. Immunol., 155, 1343-1348 (1995).
19. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, J. R., Yanneli, J. R., Appela, E. and Rosenberg, S. A. Identification of the immunodominant peptides of the Mart-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J. Exp. Med., 180, 347-352 (1995).
20. Yoshino, I., Yano, T., Murata, M., Ishida, T., Sugimachi, K., Kimura, G. and Nomoto, K. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res., 52, 775-781 (1992).
21. Schoof, D. D., Selleck, C. M., Massaro, A. M., Jung, S., Eberlein, T. J. Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to CD3 complex. Cancer Res., 50, 1138-1143 (1990).
22. Ellis, J. H., Burden, M. N., Vinogradov, D. V., Linge, C. and Crowe, J. S. Interactions of CD80 and CD86 with CD28 and CTLA4. J. Immunol., 56, 2700-2709 (1996).
23. Jerome, K. R., Domenech, N. and Finn, O. L. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J. Immunol., 151, 1654-1662 (1993).
24. Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian-Blander, J. and Barratt-Boyes, S. MUC1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol. Rev., 145, 61-89 (1995).
25. Kimura, A., Date, Y. and Sasazuki, T. DNA typing of HLA-A gene. MHC IRS, 1 (Suppl.), 13-22 (1994).
26. Takezaki, T. and Tajima, K. Epidemiological reviews of lung cancer. Jpn. J. Cancer Clin., 41, 1261-1267 (1995) (in Japanese with English abstract).